Zhu Yungang, Xu Guoping, Han Changrui, Xing Gang
Department of Radiology, Tianjin Teda Hospital Tianjin 300457, China.
Department of Medical Imaging, The Second Hospital of Tianjin Medical University Tianjin 300211, China.
Int J Clin Exp Pathol. 2021 Sep 15;14(9):920-937. eCollection 2021.
Hepatocellular carcinoma (HCC) is one of the most common and aggressive cancers. HCC shows high prevalence and lethality caused by a variety of etiologic factors. However, the underlying mechanisms and the diagnostic markers identifying patients at risk in advance has not been entirely elucidated. Long non-coding RNAs (lncRNAs) are a subgroup of non-coding RNAs greater than 200 nucleotides in length with no protein-coding capability. With the progress in sequencing technologies and bioinformatic tools, the landscape of lncRNAs is being revealed. Numerous discoveries point out that lncRNAs participate in HCC carcinogenesis and metastasis through altering cell proliferation and invasion ability, apoptosis, and chemo- or radio-sensitivity. Moreover, lncRNA is easy to detect compared to the traditional diagnostic methods. This review summarizes the mechanisms of major lncRNAs in HCC discovered in recent years and lncRNAs as early diagnostic markers for HCC.
肝细胞癌(HCC)是最常见且侵袭性最强的癌症之一。HCC因多种病因因素而具有高发病率和致死率。然而,其潜在机制以及能够提前识别高危患者的诊断标志物尚未完全阐明。长链非编码RNA(lncRNAs)是一类长度超过200个核苷酸且无蛋白质编码能力的非编码RNA亚群。随着测序技术和生物信息学工具的发展,lncRNAs的全貌正在被揭示。众多研究发现指出,lncRNAs通过改变细胞增殖和侵袭能力、细胞凋亡以及化学或放射敏感性参与HCC的致癌作用和转移过程。此外,与传统诊断方法相比,lncRNA易于检测。本综述总结了近年来发现的主要lncRNAs在HCC中的作用机制以及lncRNAs作为HCC早期诊断标志物的情况。